MARKET

ANRO

ANRO

Alto Neuroscienc
NYSE
27.04
+1.74
+6.88%
Pre Market: 27.03 -0.01 -0.04% 07:22 06/29 EDT
OPEN
25.03
PREV CLOSE
25.30
HIGH
27.11
LOW
24.89
VOLUME
5
TURNOVER
0
52 WEEK HIGH
28.44
52 WEEK LOW
2.150
MARKET CAP
948.94M
P/E (TTM)
-11.0448
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ANRO last week (0622-0626)?
Weekly Report · 7h ago
Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Aquestive Therapeutics (AQST) and Alto Neuroscience, Inc. (ANRO)
TipRanks · 3d ago
H.C. Wainwright Remains a Buy on Alto Neuroscience, Inc. (ANRO)
TipRanks · 4d ago
10 small-cap U.S. healthcare stocks with the strongest momentum grades
Seeking Alpha · 5d ago
Weekly Report: what happened at ANRO last week (0615-0619)?
Weekly Report · 06/22 10:09
Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Guardian Pharmacy Services, Inc. Class A (GRDN) and Alto Neuroscience, Inc. (ANRO)
TipRanks · 06/17 11:31
Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (ANRO) and BridgeBio Pharma (BBIO)
TipRanks · 06/15 17:10
Alto Neuroscience highlights publication in Nature Medicine on Prime-Praxol
TipRanks · 06/15 12:16
More
About ANRO
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company focused on redefining psychiatry by leveraging neurobiology to develop personalized and effective treatment options. The Company's Precision Psychiatry Platform measures brain biomarkers by analyzing EEG activity, neurocognitive assessments, wearable data, and other factors to identify which patients are likely to respond to its product candidates. Its clinical-stage pipeline includes drug candidates in bipolar depression, major depressive disorder, treatment resistant depression (TRD), and schizophrenia, and other mental health conditions. Its product candidates include ALTO-100, ALTO-300, ALTO-207, ALTO-203, ALTO-101, ALTO-202, and ALTO-208. ALTO-100 is a first-in-class, oral small molecule believed to work through enhancing neural plasticity in the hippocampus, a brain region important for both cognition and mood. ALTO-203 is an oral small molecule histamine H3 receptor inverse agonist.

Webull offers Alto Neuroscience Inc stock information, including NYSE: ANRO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANRO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANRO stock methods without spending real money on the virtual paper trading platform.